|Bid||56.32 x 38700|
|Ask||56.36 x 105300|
|Day's range||56.04 - 57.04|
|52-week range||52.62 - 71.44|
|Beta (5Y monthly)||1.00|
|PE ratio (TTM)||14.62|
|Earnings date||21 Feb 2022 - 25 Feb 2022|
|Forward dividend & yield||1.34 (2.24%)|
|Ex-dividend date||21 May 2021|
|1y target est||N/A|
HONG KONG, November 10, 2021--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today presented its advances in home dialysis solutions at the China International Import Expo (CIIE) in Shanghai. The company showcased new digitalized options that enable patients with end-stage kidney disease to perform dialysis in the comfort of their own homes, including the 5008S hemodialysis (HD) machine and a new automated peritoneal dialysis (A
FMS earnings call for the period ending September 30, 2021.
Fresenius Medical's (FMS) third-quarter earnings benefit from strong performance across the regions, Asia Pacific and Latin America.